Across TCGA pan-cancer cohorts, SNORD114-30 RNA is linked to patient survival in 10 of 34 cancer types, making it the most broadly survival-associated SNORD114-30 data layer.
The strongest signal is observed in thyroid carcinoma (THCA), where higher SNORD114-30 RNA is associated with worse overall survival. In most high-consensus cancer types, elevated SNORD114-30 expression acts as an unfavorable survival marker.
THCA, CESC, and MESO are the cancer types where SNORD114-30 RNA most reproducibly stratifies survival.
RNA survival associations by lineage
Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.